Skip to content
TCRX TScan Therapeutics, Inc. Common Stock
$1.03 -5.50% -0.06
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TCRX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 67.3M
Enterprise value 35.7M
Trailing PE -1.025
Forward PE -1.2281691
PEG Ratio 0.066625
Enterprise to EBITDA -0.288
Enterprise to revenue 3.909
Price to book MRQ 0.67575943
Price to sales TTM 7.7968907

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 9.1M
EBITDA -123821000
Diluted EPS TTM -0.96
Total Cash (MRQ) 128.1M
Current ratio (MRQ) 6.648
Operating Cash Flow (TTM) -122012000

TCRX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent TCRX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.